Status:
RECRUITING
Personalized Performance Optimization Platform
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Massachusetts Institute of Technology (MIT)
Conditions:
Sensory Science
Performance Assessment
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Crews of future long-duration exploration missions will have to cope with a wide range of stressors that present significant challenges for maintaining optimal performance. Crews will have to operate ...
Detailed Description
1. Background and Significance Crews of future long-duration space exploration missions will have to cope with a wide range of stressors that present significant challenges for maintaining optimal...
Eligibility Criteria
Inclusion
- Willingness to participate in the study
- Must be between the ages of 18 to 64
- Normal or corrected-to-normal vision and hearing
- Ability to sit still and stay awake during the experimental sessions
Exclusion
- Diagnosis with Neurological or psychiatric disorder
- Participation in a prior study associated with this protocol (due to the learning- curve on some of the behavioral tests)
Key Trial Info
Start Date :
February 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06979570
Start Date
February 22 2021
End Date
December 30 2025
Last Update
January 7 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
MIT Media Lab
Cambridge, Massachusetts, United States, 02139
2
Massachusetts General Hospital
Charlestown, Massachusetts, United States, 02427